John Spencer

John Spencer, MBA, is a seasoned professional in the fields of pharmacovigilance, risk management, and global safety, currently serving as a Senior Product Safety Scientist at Global Blood Therapeutics since November 2021. Prior experience includes significant roles at Amgen, where John led operations and technology for commercial training and managed multiple Risk Evaluation and Mitigation Strategy programs, as well as coaching teams in regulatory affairs. John has also held leadership positions in global document management at Elan Pharmaceuticals and records management at Pfizer. With a background as a Medical Specialist in the United States Army and clinical research experience at Scripps Clinic, John possesses a diverse skill set complemented by a Doctor of Education in Organizational Leadership from the University of Southern California and an MBA in International Business from California Lutheran University.